Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 24, 2008
Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional studyDominique Joly, Tilman B Drueke, Corinne Alberti, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 13, 2019
One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidismDavid A Bushinsky, Glenn M Chertow, Sunfa Cheng, et al.
Nephron. Experimental Nephrology|August 28, 2004
Exogenous bone morphogenetic protein-7 fails to attenuate renal fibrosis in rats with overload proteinuriaYukiko Ikeda, Young Ok Jung, Heungsoo Kim, et al.
Kidney International|December 11, 2002
The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidismJill S Lindberg, Sharon M Moe, William G Goodman, et al.
Seminars in Dialysis|October 6, 2004
Improving outcomes in CKD and ESRD patients: carrying the torch from training to practiceAllen R Nissenson, Rajiv Agarwal, Michael Allon, et al.
Kidney International|August 18, 2005
First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HClKevin J Martin, Harald Jüppner, Donald J Sherrard, et al.
Kidney International|January 28, 2005
Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HClSharon M Moe, Glenn M Chertow, Jack W Coburn, et al.
The New England Journal of Medicine|April 9, 2004
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysisGeoffrey A Block, Kevin J Martin, Angel L M de Francisco, et al.
Pageof 7